PMID- 35282801 OWN - NLM STAT- MEDLINE DCOM- 20230223 LR - 20230223 IS - 1476-8305 (Electronic) IS - 1028-415X (Linking) VI - 26 IP - 4 DP - 2023 Apr TI - Short-term administration of tibolone reduces inflammation and oxidative stress in the hippocampus of ovariectomized rats fed high-fat and high-fructose. PG - 275-289 LID - 10.1080/1028415X.2022.2046964 [doi] AB - Inflammation and oxidative stress are critical events involved in neurodegeneration. In animal models, it has been shown that chronic consumption of a hypercaloric diet, which leads to inflammatory processes, affects the hippocampus, a brain region fundamental for learning and memory processes. In addition, advanced age and menopause are risk factors for neurodegeneration. Hormone replacement therapy (HRT) ameliorates menopause symptoms. Tibolone (TB), a synthetic hormone, exerts estrogenic, progestogenic and androgenic effects on different tissues. We aimed to determine the effect of short-term TB administration on oxidative stress and inflammation markers in the hippocampus of ovariectomized rats fed a high-fat-and-fructose diet (HFFD). Adult female rats were ovariectomized (OVX) and fed standard diet or HFFD-consisting of 10% lard supplemented chow and 20% high-fructose syrup in the drinking water-and administered vehicle or TB (1 mg/kg for seven days). Finally, we administered hormone receptor antagonists (MPP, RU486 or FLU) to each of the OVX + HFFD + TB groups. Bodyweight, triglycerides and cholesterol, oxidative stress and inflammation markers, and the activity and expression of antioxidant enzymes were quantified in the hippocampus of each experimental group. We observed that short-term TB administration significantly reduced body weight, AGEs, MDA levels, increased SOD and GPx activity, improved GSH/GSSG ratio, and reduced IL-6 and TNF-alpha. Our findings suggest that short-term administration of TB decreases oxidative stress and reduces inflammation caused by HFFD and early estrogenic decline. These effects occurred via estrogen receptor alpha. FAU - Estrada-Cruz, Norma A AU - Estrada-Cruz NA AUID- ORCID: 0000-0003-4794-7093 AD - Unidad de Investigacion Medica en Farmacologia, Centro Medico Nacional (CMN) Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico. FAU - Manuel-Apolinar, Leticia AU - Manuel-Apolinar L AUID- ORCID: 0000-0001-8175-4215 AD - Unidad de Investigacion Medica en Enfermedades Endocrinas, CMN Siglo XXI, IMSS, Mexico City, Mexico. FAU - Segura-Uribe, Julia J AU - Segura-Uribe JJ AUID- ORCID: 0000-0002-0676-5667 AD - Subdireccion de Gestion de la Investigacion, Hospital Infantil de Mexico Federico Gomez, Mexico City, Mexico. FAU - Almanza-Perez, Julio C AU - Almanza-Perez JC AUID- ORCID: 0000-0002-9417-5500 AD - Laboratorio de Farmacologia, Departamento de Ciencias de la Salud, UAM-I, Mexico City, Mexico. FAU - Fortis-Barrera, Angeles AU - Fortis-Barrera A AUID- ORCID: 0000-0003-0923-501X AD - Laboratorio de Farmacologia, Departamento de Ciencias de la Salud, UAM-I, Mexico City, Mexico. FAU - Orozco-Suarez, Sandra AU - Orozco-Suarez S AUID- ORCID: 0000-0001-5289-8500 AD - Unidad de Investigacion Medica en Enfermedades Neurologicas, CMN Siglo XXI, IMSS, Mexico City, Mexico. FAU - Bautista-Poblet, Guadalupe AU - Bautista-Poblet G AUID- ORCID: 0000-0001-7233-186X AD - Unidad de Investigacion Medica en Farmacologia, Centro Medico Nacional (CMN) Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico. FAU - Coyoy-Salgado, Angelica AU - Coyoy-Salgado A AUID- ORCID: 0000-0001-7007-9509 AD - Catedras CONACyT-Unidad de Investigacion Medica en Enfermedades Neurologicas, IMSS, Mexico City, Mexico. FAU - Guerra-Araiza, Christian AU - Guerra-Araiza C AUID- ORCID: 0000-0002-7164-4116 AD - Unidad de Investigacion Medica en Farmacologia, Centro Medico Nacional (CMN) Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico. LA - eng PT - Journal Article DEP - 20220313 PL - England TA - Nutr Neurosci JT - Nutritional neuroscience JID - 100892202 RN - 30237-26-4 (Fructose) RN - FF9X0205V2 (tibolone) RN - 0 (Hormones) SB - IM MH - Rats MH - Female MH - Animals MH - *Fructose/adverse effects MH - *Oxidative Stress MH - Inflammation/metabolism MH - Diet, High-Fat/adverse effects MH - Body Weight MH - Hippocampus/metabolism MH - Hormones/metabolism/pharmacology OTO - NOTNLM OT - Overnutrition OT - estrogenic decline OT - high-fat-and-high-fructose diet OT - hippocampus OT - hormone receptor antagonists OT - hormone receptors OT - inflammation OT - oxidative stress EDAT- 2022/03/15 06:00 MHDA- 2023/02/25 06:00 CRDT- 2022/03/14 05:38 PHST- 2022/03/15 06:00 [pubmed] PHST- 2023/02/25 06:00 [medline] PHST- 2022/03/14 05:38 [entrez] AID - 10.1080/1028415X.2022.2046964 [doi] PST - ppublish SO - Nutr Neurosci. 2023 Apr;26(4):275-289. doi: 10.1080/1028415X.2022.2046964. Epub 2022 Mar 13.